FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

✍ Scribed by Aristides Polyzos; Nikolaos Malamos; Ioannis Boukovinas; Adamos Adamou; Nikolaos Ziras; Kostas Kalbakis; Stylianos Kakolyris; Kostas Syrigos; Pavlos Papakotoulas; Charalambos Kouroussis; Nikolaos Karvounis; Lambros Vamvakas; Charalambos Christophyllakis; Athanasios Athanasiadis; Ioannis Varthalitis; Vassilis Georgoulias; Dimitris Mavroudis

• Publisher: Springer US
• Year: 2009
• Tongue: English
• Weight: 296 KB
• Volume: 119
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-009-0468-0